Canaccord Genuity Rates Holley (HLLY) buy, $7 Price Target

Canaccord Genuity has reaffirmed its buy rating on HLLY, setting a price target of $7. This decision was announced by analyst Brian McNamara on June 29, 2026. At the start of the week, shares of HLLY traded around $2.53, showing the firm's continued confidence in the stock's potential.

Other Institutional Activity in HLLY

Institutional investors have been active in HLLY. Allspring Global Investments Holdings, LLC added 122,331 shares, bringing its total to about 9.8 million shares worth approximately $30.7 million, marking a 1.3% increase. Boston Partners also increased its stake by 285,816 shares, resulting in 6.6 million shares valued at around $20.3 million, a 4.5% increase. Meanwhile, BlackRock, Inc. reduced its holdings slightly by 8,827 shares, ending with approximately 4.9 million shares valued at $14.9 million, a 0.2% decrease. Blue Owl Capital Holdings LP grew its position by 90,252 shares to about 4.2 million shares worth $13 million, reflecting a 2.2% increase. Wasatch Advisors LP decreased its stake by 61,730 shares, resulting in 3.6 million shares valued at $11.1 million, a 1.7% reduction.

Insider Buying and Selling at Holley Inc.

There has been notable insider activity at HLLY. On June 6, 2026, Matthew Stevenson, the President and CEO, sold 97,675 shares at an average price of $2.57. Earlier, on May 8, 2026, several insiders, including James Coady, Matthew Rubel, Anita Sehgal, Graham Clempson, and Ginger Jones, each purchased 32,710 shares at no disclosed price, indicating insider confidence in the company's future.

Analysts Set New Price Targets

On June 29, 2026, Canaccord Genuity maintained its buy rating on HLLY with a $7 price target. Previously, on May 8, 2026, Benchmark also maintained a buy rating with a $4 target. Earlier in February, Telsey Advisory Group set a buy rating with a $5 target. The consensus among analysts suggests a positive outlook for HLLY, with multiple buy ratings and a mean target price reflecting optimism.

Bottom Line

Canaccord Genuity's reaffirmation of its buy rating on HLLY with a $7 target underscores the firm's confidence in the stock. The activity among institutional investors and insiders suggests varied strategies, with some increasing their stakes while others trim positions slightly. As always with 13F filings and analyst ratings, remember these reflect past actions and opinions, and actual performance may vary.